Overall rank by patents
#11,297
of 50,000 tracked assignees
USPTO PatentsView assignee record - 27 granted patents across 11 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H10D (INORGANIC ELECTRIC SEMICONDUCTOR DEVICES).
The verdict
According to USPTO PatentsView, IQE ranks #11,297 of 50,000 tracked US assignees by granted-patent volume, with 27 patents across 11 technology areas.
IQE Plc has been granted 27 US utility patents between 2017 and 2025, placing IQE Plc at #11,297 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.1 claims per patent with primary concentration in H10D (INORGANIC ELECTRIC SEMICONDUCTOR DEVICES). As a Foreign Corporation, IQE Plc is one of the more focused assignees in the PatentsView dataset. By volume, IQE sits between Inserm (27 patents, rank #11,286) and Innovative Building Technologies, Llc (27 patents, rank #11,294) - the closest US assignees by grant volume. The composite Innovation Score of 38.6/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 17 grants, compared with 8 in the 2015–2019 window, a +113% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. IQE Plc's 22.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 11 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
INSERM
27 patents
INTRADIN (SHANGHAI) MACHINERY CO., LTD.
27 patents
INTREXON ACTOBIOTICS N.V.
27 patents
IPGOAL MICROELECTRONICS (SICHUAN) CO., LTD.
27 patents
IQM FINLAND OY
27 patents
Industrial Revolution, Inc.
27 patents
Innovatech, LLC
27 patents
Innovative Building Technologies, LLC
27 patents
IQE plc
27 patents
What this shows IQE holds 27 patents at rank #11,290, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #11,290 in granted patent volume.
Other assignees with the most granted patents in IQE's primary technology class.
IQE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 3.7% |
| 2018 | 3 | 11.1% |
| 2019 | 4 | 14.8% |
| 2020 | 6 | 22.2% |
| 2021 | 6 | 22.2% |
| 2022 | 3 | 11.1% |
| 2023 | 2 | 7.4% |
| 2025partial year | 2 | 7.4% |
Top 11 of 11 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#11,297
of 50,000 tracked assignees
38.6 out of 100
How to use this portfolio
IQE's 27 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.